Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 16 | $87,189,719 |
| Sells | 0 | $0 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 20 Nov 2024 17:20 | ZBIO | Zenas BioPharma Inc | MOULDER LEON O JR | Chief Executive Officer | 18 Nov 2024 | Purchase | 7,500 | 15 | 112,500 | D |
| 20 Nov 2024 17:20 | ZBIO | Zenas BioPharma Inc | MOULDER LEON O JR | Chief Executive Officer | 19 Nov 2024 | Purchase | 2,500 | 14.57 | 36,425 | D |
| 20 Sep 2024 18:34 | ZBIO | Zenas BioPharma Inc | MOULDER LEON O JR | Chief Executive Officer | 20 Sep 2024 | Purchase | 2,633 | 18.97 | 49,948 | I |
| 20 Sep 2024 18:34 | ZBIO | Zenas BioPharma Inc | MOULDER LEON O JR | Chief Executive Officer | 20 Sep 2024 | Purchase | 2,367 | 17.88 | 42,322 | I |
| 20 Sep 2024 18:34 | ZBIO | Zenas BioPharma Inc | MOULDER LEON O JR | Chief Executive Officer | 19 Sep 2024 | Purchase | 5,000 | 17.89 | 89,450 | I |
| 20 Sep 2024 18:34 | ZBIO | Zenas BioPharma Inc | MOULDER LEON O JR | Chief Executive Officer | 18 Sep 2024 | Purchase | 10,000 | 17.91 | 179,100 | I |
| 18 Sep 2024 16:15 | ZBIO | Zenas BioPharma Inc | ENAVATE SCIENCES GP, LLC | 10% | 16 Sep 2024 | Purchase | 882,353 | 17 | 15,000,001 | I |
| 17 Sep 2024 20:56 | ZBIO | Zenas BioPharma Inc | FAIRMOUNT FUNDS MANAGEMENT LLC | Director | 16 Sep 2024 | Purchase A | 300,000 | 17 | 5,100,000 | I |
| 17 Sep 2024 19:52 | ZBIO | Zenas BioPharma Inc | LU HONGBO | Director | 13 Sep 2024 | Purchase | 58,823 | 17 | 999,991 | I |
| 16 Sep 2024 20:57 | ZBIO | Zenas BioPharma Inc | ENRIGHT PATRICK G | Director | 16 Sep 2024 | Purchase | 440,000 | 17 | 7,480,000 | I |
| 16 Sep 2024 20:54 | ZBIO | Zenas BioPharma Inc | NUNN JASON RALEIGH | Director | 16 Sep 2024 | Purchase | 441,176 | 17 | 7,499,992 | I |
| 16 Sep 2024 20:54 | ZBIO | Zenas BioPharma Inc | NUNN JASON RALEIGH | Director | 16 Sep 2024 | Purchase | 441,176 | 17 | 7,499,992 | I |
| 16 Sep 2024 20:54 | ZBIO | Zenas BioPharma Inc | FAIRMOUNT FUNDS MANAGEMENT LLC | Director | 16 Sep 2024 | Purchase | 300,000 | 17 | 5,100,000 | I |
| 16 Sep 2024 20:51 | ZBIO | Zenas BioPharma Inc | SR ONE CAPITAL MANAGEMENT, LLC | 10% | 16 Sep 2024 | Purchase | 441,176 | 17 | 7,499,992 | I |
| 16 Sep 2024 20:51 | ZBIO | Zenas BioPharma Inc | SR ONE CAPITAL MANAGEMENT, LLC | 10% | 16 Sep 2024 | Purchase | 1,352,942 | 17 | 23,000,014 | I |
| 16 Sep 2024 20:51 | ZBIO | Zenas BioPharma Inc | SR ONE CAPITAL MANAGEMENT, LLC | 10% | 16 Sep 2024 | Purchase | 441,176 | 17 | 7,499,992 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)